Heart Force Receives FDA Clearance for dBG 300 Digital Ballistocardiograph

 
July 31, 2009

July 31, 2009 – Heart Force Medical Inc. this week received FDA clearance for its digital Ballistocardiograph (dBG), a noninvasive device to assess cardiac performance by measuring and monitoring the mechanical action of the heart.

The Heart Force dBG 300 is a standalone, portable unit containing sophisticated digital sensors that assesses cardiac function by sensing the seismic (contraction) forces generated by the heart. These forces are captured by accelerometers in a sensor placed on the chest. The waveforms are transmitted to a laptop computer for analysis by a physician.

For more information: www.heartforcemedical.com

More like this

The content of this field is kept private and will not be shown publicly.
By submitting this form, you accept the Mollom privacy policy.

Related News

Resynchronization Therapy Using Nicom Hemodynamic Monitoring Improves Heart Failure Outcomes
June 3, 2011 - In a two studies published recently in Heart Rhythm Society annual meeting, Investigators from the department of cardiology in Addenbrooke's Hospital in Cambridge, U.K., found that...
Technology Integration Strategy Offers Remote Upgradability

February 11, 2011 – A technology integration strategy will provide clinicians with a host of new noninvasive, continuous measurements and patient-monitoring capabilities. The joint strategy,...

FDA Approves Noninvasive Cardiovascular Monitor

November 22, 2010 – The first noninvasive cardiovascular monitor with blood pressure and cardiac output measurements has been cleared by the U.S. Food and Drug Administration (FDA). The ccNexfin,...

View all

Related Articles

Alternatives to Invasive Cardiac Output Monitors

The company offers a monitor that uses a continuous wave doppler that can look right down into the aortic valve to check the size of the valve, and it can also look at the pulmonary valve. The...

View all